nadifloxacin and wck 771

nadifloxacin has been researched along with wck 771 in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Appelbaum, PC; Bhawsar, SB; Bozdogan, B; de Souza, NJ; Desai, VN; Deshpande, PK; Gupte, SV; Hooper, DC; Jacobs, MR; Jha, R; Khorakiwala, HF; Patel, MV; Shetty, N; Shukla, MC; Strahilevitz, J; Yeole, RD	1
Appelbaum, PC; Bhagwat, SS; Chugh, Y; De Souza, NJ; Gupte, SV; Jacobs, MR; Jafri, MA; Khorakiwala, HF; Patel, MV	1
Appelbaum, PC; Jacobs, MR	1

Reviews

1 review(s) available for nadifloxacin and wck 771

Article	Year
Nadifloxacin: a quinolone for topical treatment of skin infections and potential for systemic use of its active isomer, WCK 771. Expert opinion on pharmacotherapy, 2006, Volume: 7, Issue:14 Topics: Acne Vulgaris; Administration, Topical; Adolescent; Adult; Animals; Anti-Infective Agents; Clinical Trials as Topic; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Quinolizines; Staphylococcal Skin Infections	2006

Article

Year

Nadifloxacin: a quinolone for topical treatment of skin infections and potential for systemic use of its active isomer, WCK 771.

Expert opinion on pharmacotherapy, 2006, Volume: 7, Issue:14

Topics: Acne Vulgaris; Administration, Topical; Adolescent; Adult; Animals; Anti-Infective Agents; Clinical Trials as Topic; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Quinolizines; Staphylococcal Skin Infections

2006

Other Studies

2 other study(ies) available for nadifloxacin and wck 771

Article	Year
A chiral benzoquinolizine-2-carboxylic acid arginine salt active against vancomycin-resistant Staphylococcus aureus. Journal of medicinal chemistry, 2005, Aug-11, Volume: 48, Issue:16 Topics: Animals; Anti-Bacterial Agents; Area Under Curve; Clinical Trials, Phase I as Topic; Dogs; Drug Resistance, Multiple, Bacterial; Female; Fluoroquinolones; Half-Life; Humans; Infusions, Intravenous; Injections, Intravenous; Male; Methicillin Resistance; Mice; Microbial Sensitivity Tests; Mutation; Prodrugs; Quinolizines; Rats; Rats, Wistar; Staphylococcal Infections; Staphylococcus aureus; Stereoisomerism; Structure-Activity Relationship; Vancomycin Resistance	2005
Antistaphylococcal activity of WCK 771, a tricyclic fluoroquinolone, in animal infection models. Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:12 Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Area Under Curve; Bacterial Proteins; Cellulitis; Drug Resistance, Bacterial; Fluoroquinolones; Half-Life; Injections, Subcutaneous; Methicillin Resistance; Mice; Microbial Sensitivity Tests; Multidrug Resistance-Associated Proteins; Quinolizines; Sepsis; Staphylococcal Infections; Staphylococcus aureus	2004

Article

Year

A chiral benzoquinolizine-2-carboxylic acid arginine salt active against vancomycin-resistant Staphylococcus aureus.

Journal of medicinal chemistry, 2005, Aug-11, Volume: 48, Issue:16

Topics: Animals; Anti-Bacterial Agents; Area Under Curve; Clinical Trials, Phase I as Topic; Dogs; Drug Resistance, Multiple, Bacterial; Female; Fluoroquinolones; Half-Life; Humans; Infusions, Intravenous; Injections, Intravenous; Male; Methicillin Resistance; Mice; Microbial Sensitivity Tests; Mutation; Prodrugs; Quinolizines; Rats; Rats, Wistar; Staphylococcal Infections; Staphylococcus aureus; Stereoisomerism; Structure-Activity Relationship; Vancomycin Resistance

2005

Antistaphylococcal activity of WCK 771, a tricyclic fluoroquinolone, in animal infection models.

Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:12

Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Area Under Curve; Bacterial Proteins; Cellulitis; Drug Resistance, Bacterial; Fluoroquinolones; Half-Life; Injections, Subcutaneous; Methicillin Resistance; Mice; Microbial Sensitivity Tests; Multidrug Resistance-Associated Proteins; Quinolizines; Sepsis; Staphylococcal Infections; Staphylococcus aureus

2004